Table 2. Liver function tests of the study population.
Investigation | Range | Number of patients |
TSB (mg/dL) | ≤1.2 | 30 (47.6%) |
1.3-2.0 | 19 (30.2%) | |
2.1-3 | 10 (15.8%) | |
3.1-4 | 4 (6.3%) | |
>4 | 0 | |
AST (U/L) | ≤40 | 37 (58.7%) |
41-100 | 20 (31.7%) | |
101-200 | 6 (9.5%) | |
201-300 | 0 | |
>300 | 0 | |
ALT (U/L) | ≤40 | 38 (60.3%) |
41-100 | 19 (30.1%) | |
101-200 | 5 (7.9%) | |
201-300 | 1 (1.6%) | |
>300 | 0 |